Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Hepatorenal syndrome: Current concepts and future perspectives

Chan-Young Jung, Jai Won Chang

Clin Mol Hepatol. 2023;29(4):891-908. Published online April 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0024

View: 6028 Download: 1,201 Web of Science: 2 Crossref: 3

Acute kidney injury in liver cirrhosis: new definition and application

Florence Wong

Clin Mol Hepatol. 2016;22(4):415-422. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0056

View: 13948 Download: 760 Web of Science: 52 Crossref: 55

Original Article

Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal

Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(2):185-191. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.185

View: 9183 Download: 110 Web of Science: 31 Crossref: 26

Case Report

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome

Hae Rim Kim, Young Sun Lee, Hyung Joon Yim, Hyun Joo Lee, Ja Young Ryu, Hyun Jung Lee, Eileen L. Yoon, Sun Jae Lee, Jong Jin Hyun, Sung Woo Jung, Ja Seol Koo, Rok Sun Choung, Sang Woo Lee, Jai Hyun Choi

Clin Mol Hepatol. 2013;19(4):417-420. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.417

View: 7851 Download: 109 Crossref: 6

A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease

Heon Ju Lee, Myung Jin Oh

Clin Mol Hepatol. 2013;19(2):179-184. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.179

View: 7017 Download: 77 Crossref: 9

7

The Korean Journal of Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

Oh Sang Kwon, M.D.

Clin Mol Hepatol. 2010;16(1):100-102. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.100

View: 3663 Download: 27

1 |

Viewed By 5243	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5177	MAFLD: How is it different from NAFLD?
Viewed By 5095	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3816	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3746	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search